Log in
RegisterSite and Treatment as fixed. [General Statistics]
Hi Dr Ripal,
BE in oncology often means a parallel design, so I think you will need a simple two-factor model with treatment and site as fixed effects in a PROC GLM or equivalent.
❝ We have been asked by USFDA to include site/centre effect in one of our multicenteric oncology bioequivalence study. Kindly suggest which statistical tests should be used for the same.
BE in oncology often means a parallel design, so I think you will need a simple two-factor model with treatment and site as fixed effects in a PROC GLM or equivalent.
—
Pass or fail!
ElMaestro
Pass or fail!
ElMaestro
Complete thread:
- how to evaluate site/center effect in multicentric bioequivalence study? Dr Ripal 2016-06-09 14:08 [General Statistics]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- how to evaluate site/center effect in multicentric bioequivalence study? BE-proff 2016-06-09 15:03
- See some previous topics mittyri 2016-06-09 15:21
- Site and Treatment as fixed.ElMaestro 2016-06-09 19:39
- Site and Treatment as fixed. Dr Ripal 2016-06-10 05:57
- Site and Treatment as fixed. ElMaestro 2016-06-10 07:17
- Site and Treatment as fixed. Dr Ripal 2016-06-10 05:57
- how to evaluate site/center effect in multicentric bioequivalence study? DavidManteigas 2016-06-15 18:30
Ing. Helmut Schütz